Background: Brain metastasis velocity (BMV) predicts outcomes after initial distant brain failure (DBF) following upfront stereotactic radiosurgery (SRS). We developed an integrated model of clinical predictors and pre-SRS MRI-derived radiomic scores (R-scores) to identify high-BMV (BMV-H) patients upon initial identification of brain metastases (BMs). Methods: In total, 256 patients with BMs treated with upfront SRS alone were retrospectively included. R-scores were built from 1246 radiomic features in 2 target volumes by using the Extreme Gradient Boosting algorithm to predict BMV-H groups, as defined by BMV at least 4 or leptomeningeal disease at first DBF. Two R-scores and 3 clinical predictors were integrated into a predictive clinico-radiomic (CR) model. Results: The related R-scores showed signicant differences between BMV-H and low BMV (BMV-L), as defined by BMV less than 4 or no DBF (P
CITATION STYLE
Hsu, C. Y., Xiao, F., Liu, K. L., Chen, T. L., Lee, Y. C., & Wang, W. (2020). Radiomic analysis of magnetic resonance imaging predicts brain metastases velocity and clinical outcome after upfront radiosurgery. Neuro-Oncology Advances, 2(1). https://doi.org/10.1093/noajnl/vdaa100
Mendeley helps you to discover research relevant for your work.